Pacira Biosciences
PCRX
#5888
Rank
HK$6.24 B
Marketcap
HK$135.26
Share price
2.06%
Change (1 day)
-34.92%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2024 (TTM): HK$0.78 Billion

According to Pacira Biosciences 's latest financial reports the company's current earnings are HK$0.69 Billion. In 2023 the company made an earning of HK$0.48 Billion, an increase over its 2022 earnings that were of HK$0.10 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$0.78 B63.65%
2023 HK$0.48 B363.85%
2022 HK$0.10 B-76.42%
2021 HK$0.43 B180.76%
2020 HK$0.15 B-286.92%
2019 -HK$83.65 Million2428.94%
2018 -HK$3.31 Million-99%
2017 -HK$0.34 Billion12.23%
2016 -HK$0.3 Billion-1885.05%
2015 HK$16.49 M-115.65%
2014 -HK$0.11 Billion-78.95%
2013 -HK$0.51 Billion21.55%
2012 -HK$0.42 Billion41.18%
2011 -HK$0.3 Billion57.4%
2010 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$29.29 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.62 Billion-178.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.82 Billion-204.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.38 Billion-147.87%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.34 Billion-270.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.66 Billion-310.88%๐Ÿ‡บ๐Ÿ‡ธ USA